D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 82 Citations 28,405 292 World Ranking 8841 National Ranking 108

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Myocardial infarction

Leif Thuesen mainly investigates Surgery, Internal medicine, Myocardial infarction, Cardiology and Angioplasty. The Surgery study combines topics in areas such as Coronary artery disease and Percutaneous coronary intervention. His Internal medicine research is multidisciplinary, incorporating perspectives in Placebo and Endocrinology.

In general Myocardial infarction study, his work on Conventional PCI and Target lesion often relates to the realm of In patient, thereby connecting several areas of interest. His research integrates issues of Stroke and Clinical trial in his study of Cardiology. His study looks at the intersection of Angioplasty and topics like Revascularization with Paclitaxel, Major complication, Patient age, Percutaneous and Long term outcomes.

His most cited work include:

  • A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction (1103 citations)
  • BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS (797 citations)
  • Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial (786 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Internal medicine, Cardiology, Surgery, Myocardial infarction and Percutaneous coronary intervention. His work in the fields of Conventional PCI, Hazard ratio and Sirolimus overlaps with other areas such as In patient. His work carried out in the field of Cardiology brings together such families of science as Stroke and Coronary stent.

His biological study spans a wide range of topics, including Nuclear medicine and Cohort. His studies deal with areas such as Thrombosis and Randomized controlled trial as well as Myocardial infarction. His Stent study combines topics from a wide range of disciplines, such as Coronary artery disease and Mace.

He most often published in these fields:

  • Internal medicine (63.08%)
  • Cardiology (56.72%)
  • Surgery (38.63%)

What were the highlights of his more recent work (between 2011-2021)?

  • Internal medicine (63.08%)
  • Cardiology (56.72%)
  • Surgery (38.63%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Cardiology, Surgery, Myocardial infarction and Percutaneous coronary intervention. His work on Hazard ratio, Sirolimus and Stroke is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science. His Cardiology research is multidisciplinary, incorporating elements of Restenosis and Coronary stent.

His research investigates the connection between Surgery and topics such as Clopidogrel that intersect with problems in Discontinuation. The various areas that Leif Thuesen examines in his Myocardial infarction study include Thrombosis and Proportional hazards model. His Percutaneous coronary intervention study also includes

  • Coronary artery disease which is related to area like Cardiovascular agent,
  • Angioplasty that intertwine with fields like Balloon.

Between 2011 and 2021, his most popular works were:

  • Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction (404 citations)
  • Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. (384 citations)
  • Drug-Eluting vs Bare-Metal Stents in Primary Angioplasty: A Pooled Patient-Level Meta-analysis of Randomized Trials (209 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Myocardial infarction

His main research concerns Myocardial infarction, Surgery, Internal medicine, Cardiology and Percutaneous coronary intervention. He combines subjects such as Restenosis and Hazard ratio with his study of Myocardial infarction. The study incorporates disciplines such as Coronary artery disease, Stent thrombosis and Nuclear medicine in addition to Surgery.

Leif Thuesen works mostly in the field of Cardiology, limiting it down to topics relating to Stroke and, in certain cases, Relative risk. The concepts of his Percutaneous coronary intervention study are interwoven with issues in ST segment, Angioplasty, Coronary occlusion and Intention-to-treat analysis. His Angioplasty research is multidisciplinary, relying on both Framingham Risk Score and Balloon.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction

Henning R. Andersen;Torsten T. Nielsen;Klaus Rasmussen;Leif Thuesen.
The New England Journal of Medicine (2003)

1812 Citations

Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome

Henning Rud Andersen;Jens Cosedis Nielsen;Poul Erik Bloch Thomsen;Leif Thuesen.
The Lancet (1997)

1214 Citations

BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS

J O Jørgensen;S A Pedersen;L Thuesen;J Jørgensen.
The Lancet (1989)

1032 Citations

Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study

Terje K. Steigen;Michael Maeng;Rune Wiseth;Andrejs Erglis.
Circulation (2006)

918 Citations

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

Patrick W Serruys;John A Ormiston;Yoshinobu Onuma;Evelyn Regar.
The Lancet (2009)

902 Citations

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

John A Ormiston;Patrick W Serruys;Evelyn Regar;Dariusz Dudek.
The Lancet (2008)

801 Citations

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

Hans Erik Bøtker;Rajesh Kharbanda;Michael R Schmidt;Morten Bøttcher.
The Lancet (2010)

786 Citations

Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis: 12-Month Clinical and Imaging Outcomes

Patrick W. Serruys;Yoshinobu Onuma;Dariusz Dudek;Pieter C. Smits.
Journal of the American College of Cardiology (2010)

700 Citations

System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention

Christian Juhl Terkelsen;Jacob Thorsted Sørensen;Michael Maeng;Lisette Okkels Jensen.
JAMA (2010)

669 Citations

Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome

H.R Andersen;L Thuesen;J.P Bagger;T Vesterlund.
The Lancet (1994)

616 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Leif Thuesen

Patrick W. Serruys

Patrick W. Serruys

National University of Ireland, Galway

Publications: 389

Antonio Colombo

Antonio Colombo

Vita-Salute San Raffaele University

Publications: 156

Hans Erik Bøtker

Hans Erik Bøtker

Aarhus University Hospital

Publications: 156

Gregg W. Stone

Gregg W. Stone

Columbia University Medical Center

Publications: 155

Yoshinobu Onuma

Yoshinobu Onuma

National University of Ireland, Galway

Publications: 145

Stephan Windecker

Stephan Windecker

University of Bern

Publications: 126

Carlo Di Mario

Carlo Di Mario

Careggi University Hospital

Publications: 100

Hector M. Garcia-Garcia

Hector M. Garcia-Garcia

MedStar Washington Hospital Center

Publications: 95

Emmanouil S. Brilakis

Emmanouil S. Brilakis

Abbott Northwestern Hospital

Publications: 95

Seung-Jung Park

Seung-Jung Park

University of Ulsan

Publications: 93

Roxana Mehran

Roxana Mehran

Icahn School of Medicine at Mount Sinai

Publications: 91

Manel Sabaté

Manel Sabaté

University of Barcelona

Publications: 91

Adnan Kastrati

Adnan Kastrati

Technical University of Munich

Publications: 87

William Wijns

William Wijns

National University of Ireland, Galway

Publications: 85

Ron Waksman

Ron Waksman

MedStar Washington Hospital Center

Publications: 83

Azeem Latib

Azeem Latib

Montefiore Medical Center

Publications: 83

Trending Scientists

Xiangyang Zhu

Xiangyang Zhu

Shanghai Jiao Tong University

Robert Libby

Robert Libby

Cornell University

Andrew J. Patton

Andrew J. Patton

Duke University

Marek Behr

Marek Behr

RWTH Aachen University

Keh-Chih Hwang

Keh-Chih Hwang

Tsinghua University

Guoqiang Feng

Guoqiang Feng

Central China Normal University

Cory Dean

Cory Dean

Columbia University

Mark I. Rees

Mark I. Rees

Swansea University

Nigel E. Stork

Nigel E. Stork

Griffith University

Liléia Diotaiuti

Liléia Diotaiuti

Oswaldo Cruz Foundation

Brendon A. Bradley

Brendon A. Bradley

University of Canterbury

Jeremy G. Venditti

Jeremy G. Venditti

Simon Fraser University

Richard E. Peltier

Richard E. Peltier

University of Massachusetts Amherst

John DeLamater

John DeLamater

University of Wisconsin–Madison

Caterina Pesce

Caterina Pesce

Sapienza University of Rome

Ortwin Gerhard

Ortwin Gerhard

Max Planck Society

Something went wrong. Please try again later.